Published in Brain on July 01, 2013
β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci (2015) 1.79
Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain (2015) 1.58
What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol (2014) 1.29
In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain. J Neurosci (2016) 1.00
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography. Brain (2016) 0.99
Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease. Brain (2014) 0.96
Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends Neurosci (2016) 0.87
Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Neuroimage Clin (2014) 0.83
Functional Connectivity in Multiple Cortical Networks Is Associated with Performance Across Cognitive Domains in Older Adults. Brain Connect (2015) 0.82
Progression of Seed-Induced Aβ Deposition within the Limbic Connectome. Brain Pathol (2015) 0.79
Loss of functional connectivity is greater outside the default mode network in nonfamilial early-onset Alzheimer's disease variants. Neurobiol Aging (2015) 0.78
Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Brain (2016) 0.76
Amyloid and tau PET demonstrate region-specific associations in normal older people. Neuroimage (2017) 0.76
A spectral graph regression model for learning brain connectivity of Alzheimer's disease. PLoS One (2015) 0.75
Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease. Cereb Cortex (2016) 0.75
Tau and amyloid-β proteins distinctively associate to functional network changes in the aging brain. Alzheimers Dement (2017) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage (2002) 49.90
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med (1995) 42.32
The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci (2008) 29.64
Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci (2009) 27.56
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol (2004) 21.56
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A (2004) 19.84
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Searching for a baseline: functional imaging and the resting human brain. Nat Rev Neurosci (2001) 18.23
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05
Separating respiratory-variation-related fluctuations from neuronal-activity-related fluctuations in fMRI. Neuroimage (2006) 10.95
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol (1997) 10.06
Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J Neurophysiol (2009) 9.94
Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69
The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol (2011) 8.79
Pathways towards and away from Alzheimer's disease. Nature (2004) 8.72
APP processing and synaptic function. Neuron (2003) 8.37
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol (2006) 8.15
Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology (2002) 7.73
Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70
Organization, development and function of complex brain networks. Trends Cogn Sci (2004) 7.62
Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron (2005) 7.53
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain (2009) 7.20
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science (1984) 6.86
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab (1990) 6.62
Propagation of tau pathology in a model of early Alzheimer's disease. Neuron (2012) 6.23
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain (2008) 5.89
Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A (2003) 5.64
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex (1992) 5.57
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. Brain (2006) 5.42
Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat Neurosci (2011) 5.40
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem (2003) 5.34
Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol (2008) 5.29
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med (2005) 5.10
Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci (2010) 5.03
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol (2009) 4.55
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging (2007) 4.47
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol (2011) 4.38
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Surface-based and probabilistic atlases of primate cerebral cortex. Neuron (2007) 3.74
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci (1987) 3.39
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol (1991) 3.35
A network dysfunction perspective on neurodegenerative diseases. Nature (2006) 3.33
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron (2012) 3.07
A network diffusion model of disease progression in dementia. Neuron (2012) 3.03
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ ) deposition. Proc Natl Acad Sci U S A (2010) 2.80
PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment. Neurology (2007) 2.63
Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol (1989) 2.61
Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol (2011) 2.57
Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science (2008) 2.53
Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci (2002) 2.35
The organization of local and distant functional connectivity in the human brain. PLoS Comput Biol (2010) 2.28
Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett (2004) 2.16
Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.13
The neuropathology of Alzheimer's disease: a review with pathogenetic, aetiological and therapeutic considerations. Mech Ageing Dev (1985) 2.08
Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path. J Neurosci (1998) 2.00
The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes. Brain Res (1989) 1.93
Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques. Neurosci Lett (1989) 1.91
Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci (2001) 1.88
Stepwise connectivity of the modal cortex reveals the multimodal organization of the human brain. J Neurosci (2012) 1.82
A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett (2002) 1.79
The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol (2011) 1.79
Amygdaloid changes in aging and dementia. Arch Neurol (1980) 1.67
Alzheimer's disease: progress in prediction. Lancet Neurol (2010) 1.66
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain (2012) 1.58
PET imaging of amyloid in Alzheimer's disease. Lancet Neurol (2004) 1.55
Mechanisms of protein seeding in neurodegenerative diseases. JAMA Neurol (2013) 1.51
Senile plaques in temporal lobe epilepsy. Acta Neuropathol (1994) 1.44
Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain (2010) 1.44
Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data. Ann Neurol (2011) 1.40
Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease. Neuroscience (1987) 1.38
Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry Res (2011) 1.35
Longitudinal patterns of β-amyloid deposition in nondemented older adults. Arch Neurol (2011) 1.32
Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease. Biol Psychiatry (2010) 1.29
Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc Natl Acad Sci U S A (1993) 1.29
Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology (2011) 1.26
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment. Brain (2011) 1.23
Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain. J Neurosci (2012) 1.23
The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. Cereb Cortex (2011) 1.23
Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol (1997) 1.23
Neural inputs into the nucleus basalis of the substantia innominata (Ch4) in the rhesus monkey. Brain (1984) 1.21
The ups and downs of Abeta. Nat Med (2006) 1.04
Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci Lett (1986) 1.02
Pathological alterations in the amygdala in Alzheimer's disease. Neuroscience (1990) 1.00
The topographic distribution of senile plaques and neurofibrillary tangles in the brains of non-demented persons of different ages. Neuropathol Appl Neurobiol (1987) 0.98
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci (2009) 12.05
The influence of head motion on intrinsic functional connectivity MRI. Neuroimage (2011) 10.49
The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol (2011) 8.79
Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci (2009) 4.50
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol (2010) 3.64
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. Arch Neurol (2011) 2.81
Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77
Spherical demons: fast diffeomorphic landmark-free surface registration. IEEE Trans Med Imaging (2009) 2.74
Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol (2011) 2.57
The A4 study: stopping AD before symptoms begin? Sci Transl Med (2014) 2.43
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study. Neurology (2012) 2.26
Effects of registration regularization and atlas sharpness on segmentation accuracy. Med Image Anal (2008) 2.24
Individual variability in functional connectivity architecture of the human brain. Neuron (2013) 2.00
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98
Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia (2012) 1.90
Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain (2011) 1.89
Brain amyloid and cognition in Lewy body diseases. Mov Disord (2012) 1.87
Stepwise connectivity of the modal cortex reveals the multimodal organization of the human brain. J Neurosci (2012) 1.82
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci (2012) 1.76
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One (2010) 1.65
Transferable, multiple antibiotic and mercury resistance in Atlantic Canadian isolates of Aeromonas salmonicida subsp. salmonicida is associated with carriage of an IncA/C plasmid similar to the Salmonella enterica plasmid pSN254. J Antimicrob Chemother (2008) 1.62
Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia (2011) 1.60
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease. Alzheimers Dement (2011) 1.59
Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest (2003) 1.59
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease. Alzheimers Dement (2011) 1.54
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging (2012) 1.49
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals. Neurobiol Aging (2012) 1.43
Learning task-optimal registration cost functions for localizing cytoarchitecture and function in the cerebral cortex. IEEE Trans Med Imaging (2010) 1.42
Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci (2011) 1.41
Nonlinear registration of diffusion MR images based on fiber bundles. Med Image Comput Comput Assist Interv (2007) 1.34
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology (2012) 1.33
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Measuring and comparing brain cortical surface area and other areal quantities. Neuroimage (2012) 1.27
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Preclinical Alzheimer disease-the challenges ahead. Nat Rev Neurol (2012) 1.25
A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline. Hum Mol Genet (2012) 1.22
Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol Aging (2011) 1.16
A surface-based analysis of language lateralization and cortical asymmetry. J Cogn Neurosci (2013) 1.15
CML24, regulated in expression by diverse stimuli, encodes a potential Ca2+ sensor that functions in responses to abscisic acid, daylength, and ion stress. Plant Physiol (2005) 1.14
Mapping the road forward in Alzheimer's disease. Sci Transl Med (2011) 1.14
Failure to modulate attentional control in advanced aging linked to white matter pathology. Cereb Cortex (2011) 1.12
Mild to moderate Alzheimer dementia with insufficient neuropathological changes. Ann Neurol (2014) 1.12
Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data. Neuroimage (2013) 1.11
MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. Arch Neurol (2003) 1.08
Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord (2012) 1.07
A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807. J Labelled Comp Radiopharm (2013) 1.03
The role of neuroimaging in elucidating delirium pathophysiology. J Gerontol A Biol Sci Med Sci (2006) 1.02
Instrumental activities of daily living impairment is associated with increased amyloid burden. Dement Geriatr Cogn Disord (2011) 1.01
Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. J Neurosci (2014) 1.00
A unified framework for MR based disease classification. Inf Process Med Imaging (2009) 0.98
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Assessment of cognition in early dementia. Alzheimers Dement (2011) 0.94
Early risk assessment for Alzheimer's disease. Alzheimers Dement (2009) 0.94
On removing interpolation and resampling artifacts in rigid image registration. IEEE Trans Image Process (2012) 0.93
Consistency Clustering: A Robust Algorithm for Group-wise Registration, Segmentation and Automatic Atlas Construction in Diffusion MRI. Int J Comput Vis (2009) 0.92
Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA? Ann Neurol (2013) 0.92
Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non-demented elderly adults. Hum Brain Mapp (2011) 0.90
Intelligence quotient-adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion. J Int Neuropsychol Soc (2007) 0.89
Joint modeling of imaging and genetics. Inf Process Med Imaging (2013) 0.88
Charting a path toward combination therapy for Alzheimer's disease. Expert Rev Neurother (2014) 0.87
Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. N Engl J Med (2014) 0.87
The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults. Cereb Cortex (2012) 0.87
Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites. Regul Toxicol Pharmacol (2002) 0.86
Effects of registration regularization and atlas sharpness on segmentation accuracy. Med Image Comput Comput Assist Interv (2007) 0.85
Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. Curr Alzheimer Res (2014) 0.84
A universal and efficient method to compute maps from image-based prediction models. Med Image Comput Comput Assist Interv (2014) 0.84
Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease. J Nucl Med (2004) 0.84
Towards Effcient Label Fusion by Pre-Alignment of Training Data. Med Image Comput Comput Assist Interv (2011) 0.83
Network assemblies in the functional brain. Curr Opin Neurol (2012) 0.83
Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci (2013) 0.83
Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2012) 0.83
Effect of feed restriction on Hershberger and pubertal male assay endpoints. Birth Defects Res B Dev Reprod Toxicol (2003) 0.81
PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies. Neurodegener Dis (2015) 0.80
Building a roadmap for developing combination therapies for Alzheimer's disease. Expert Rev Neurother (2015) 0.80
Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. J Neuropsychiatry Clin Neurosci (2014) 0.80
Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord (2015) 0.79
SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. Curr Alzheimer Res (2014) 0.79
Dementia: new criteria but no new treatments. Lancet Neurol (2012) 0.79
Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria. Dement Geriatr Cogn Disord (2016) 0.79
Evaluation of potential modes of action of inhaled ethylbenzene in rats and mice. Toxicol Sci (2003) 0.79
The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors. Neuroimage (2011) 0.79
Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research. Stat Med (2004) 0.77
A cautionary analysis of STAPLE using direct inference of segmentation truth. Med Image Comput Comput Assist Interv (2014) 0.77
A new species of myxozoan (Myxosporea) from the brain and spinal cord of rainbow trout (Oncorhynchus mykiss) from Idaho. J Parasitol (2008) 0.77
Reply: Beyond the limits of detection: failure of PiB imaging to capture true Aβ burden. Mov Disord (2013) 0.76
Does hippocampal FDG-PET asymmetry predict verbal memory dysfunction after left temporal lobectomy? Epilepsy Behav (2009) 0.76
The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease. Alzheimer Dis Assoc Disord (2016) 0.75
Concomitant antibiotic and mercury resistance among gastrointestinal microflora of feral brook trout, Salvelinus fontinalis. Curr Microbiol (2012) 0.75